Suppr超能文献

大鼠和慢性肾衰竭患者体内甲基胍的组织及血细胞浓度

Tissue and blood cell concentration of methylguanidine in rats and patients with chronic renal failure.

作者信息

Orita Y, Ando A, Tsubakihara Y, Mikami H, Kikuchi T, Nakata K, Abe H

出版信息

Nephron. 1981;27(1):35-9. doi: 10.1159/000182017.

Abstract

Methylguanidine concentration in blood cell of nondialysed patients with chronic renal failure was quantitatively determined by the method of the present authors. We also determined tissue methylguanidine concentrations in the liver, blood cell, kidney, colon, muscle and brain of uremic rat experimentally produced by Platt's method. Methylguanidine concentrations in blood cell and tissues except the brain of the uremic rats and in blood cell of the uremic patients were 5--7 times higher than those in their serums. An increased methylguanidine concentration in the liver of the uremic rat receiving 40% protein diet was observed. These results imply that methylguanidine acts as one of the important uremic toxins in the intracellular space except for the brain, and suggest that the liver specifically affects the formation of methylguanidine.

摘要

采用作者本人的方法对未透析的慢性肾衰竭患者血细胞中的甲基胍浓度进行了定量测定。我们还通过普拉特方法实验性制备了尿毒症大鼠,并测定了其肝脏、血细胞、肾脏、结肠、肌肉和大脑中的组织甲基胍浓度。尿毒症大鼠除大脑外的血细胞和组织以及尿毒症患者血细胞中的甲基胍浓度比其血清中的高5 - 7倍。观察到接受40%蛋白质饮食的尿毒症大鼠肝脏中甲基胍浓度升高。这些结果表明,甲基胍是除大脑外细胞内空间中重要的尿毒症毒素之一,并提示肝脏对甲基胍的形成有特异性影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验